Aldeyra (ALDX) announced FDA acceptance of its resubmitted market application for reproxalap and an expansion of its option agreement with AbbVie (ABBV). Read more here.

Shares of Aldeyra Therapeutics gained after the Food and Drug Administration accepted the company's resubmitted new drug application for its treatment of dry eye disease for review. The stock rose 11% ...

Deluxe , a Trusted Payments and Data Company, has announced an inducement grant in connection with the recent hiring of Kimberly D. Cross as its Senior Vice President, Chief Human Resources Officer.

Rockwell Automation, Inc. , the global leader in industrial automation and digital transformation, today announces the opening of its 33rd annual Automation Fair® in Anaheim, California. This ...

A Prescription Drug User Fee Act date of April 2, 2025 has been assigned to the resubmitted application. The Food and Drug Administration (FDA) has accepted for review the resubmitted New Drug ...

AbbVie (NYSE:ABBV) shares snapped eight consecutive sessions of losses as the stock closed up 0.78% at $166.28. The North ...